Pyrrolo[1,2-a]quinoxaline derivatives as Adenosine A3 receptor modulators and uses thereof
申请人:Faust Pharmaceuticals
公开号:EP1798233A1
公开(公告)日:2007-06-20
The present invention provides new compounds of formula (I) displaying high affinity for adenosine A3 receptors. It also provides modulators of adenosine A3 receptors. It further provides compounds for the treatment and/or prophylaxis of conditions and diseases where adenosine A3 receptor plays a role. Pharmaceutical compositions for the treatment and/or prophylaxis of conditions and diseases where adenosine A3 receptors play a role are also described.
本发明提供了具有高亲和力的式(I)新化合物,用于腺苷A3受体。它还提供了腺苷A3受体的调节剂。此外,还提供了用于治疗和/或预防腺苷A3受体在疾病和病症中发挥作用的化合物。还描述了用于治疗和/或预防腺苷A3受体在疾病和病症中发挥作用的药物组合物。